-transparent.png){kind=logo}
Amiodarone, an iodine-containing drug used frequently in the treatment of cardiac arrhythmias and angina pectoris, has many effects on thyroid hormone metabolism, including decreasing the production of triiodothyronine (T3) and decreasing the clearance of thyroxine and reverse T3. These effects result in elevated serum thyroxine and reverse T3 concentrations and decreased serum T3 concentrations. In addition, iodine-induced hyperthyroidism or hypothyroidism may occur in patients chronically treated with amiodarone. This study is a retrospective analysis of the incidence of thyroid dysfunction in Lucca and Pisa, West Tuscany, Italy, and in Worcester, Massachusetts. Hyperthyroidism was a more frequent (9.6%) complication of amiodarone therapy in West Tuscany, where iodine intake is moderately low; hypothyroidism was more frequent (22%) in Worcester, where iodine intake is sufficient. In patients receiving chronic amiodarone therapy, clinically suspected hyperthyroidism is best confirmed by showing elevations in serum T3 or free T3 concentrations; hypothyroidism is best diagnosed by showing an elevated serum thyrotrophin concentration. Thyroid function should be carefully monitored in patients receiving amiodarone chronically, especially if they have goiter or Hashimoto's thyroiditis.
E Martino, and
M Safran, and
F Aghini-Lombardi, and
R Rajatanavin, and
M Lenziardi, and
M Fay, and
A Pacchiarotti, and
N Aronin, and
E Macchia, and
C Haffajee
January 1987,
Journal of the American College of Cardiology,
E Martino, and
M Safran, and
F Aghini-Lombardi, and
R Rajatanavin, and
M Lenziardi, and
M Fay, and
A Pacchiarotti, and
N Aronin, and
E Macchia, and
C Haffajee
April 1984,
The New Zealand medical journal,
E Martino, and
M Safran, and
F Aghini-Lombardi, and
R Rajatanavin, and
M Lenziardi, and
M Fay, and
A Pacchiarotti, and
N Aronin, and
E Macchia, and
C Haffajee
November 1985,
Revista medica de Chile,
E Martino, and
M Safran, and
F Aghini-Lombardi, and
R Rajatanavin, and
M Lenziardi, and
M Fay, and
A Pacchiarotti, and
N Aronin, and
E Macchia, and
C Haffajee
September 2010,
Southern medical journal,
E Martino, and
M Safran, and
F Aghini-Lombardi, and
R Rajatanavin, and
M Lenziardi, and
M Fay, and
A Pacchiarotti, and
N Aronin, and
E Macchia, and
C Haffajee
January 1993,
Trends in endocrinology and metabolism: TEM,
E Martino, and
M Safran, and
F Aghini-Lombardi, and
R Rajatanavin, and
M Lenziardi, and
M Fay, and
A Pacchiarotti, and
N Aronin, and
E Macchia, and
C Haffajee
February 2013,
Arquivos brasileiros de endocrinologia e metabologia,
E Martino, and
M Safran, and
F Aghini-Lombardi, and
R Rajatanavin, and
M Lenziardi, and
M Fay, and
A Pacchiarotti, and
N Aronin, and
E Macchia, and
C Haffajee
January 2012,
Medicina,
E Martino, and
M Safran, and
F Aghini-Lombardi, and
R Rajatanavin, and
M Lenziardi, and
M Fay, and
A Pacchiarotti, and
N Aronin, and
E Macchia, and
C Haffajee
July 1985,
Medicina clinica,
E Martino, and
M Safran, and
F Aghini-Lombardi, and
R Rajatanavin, and
M Lenziardi, and
M Fay, and
A Pacchiarotti, and
N Aronin, and
E Macchia, and
C Haffajee
November 2001,
Japanese circulation journal,
E Martino, and
M Safran, and
F Aghini-Lombardi, and
R Rajatanavin, and
M Lenziardi, and
M Fay, and
A Pacchiarotti, and
N Aronin, and
E Macchia, and
C Haffajee
November 2007,
Nihon rinsho. Japanese journal of clinical medicine,
